These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3534798)

  • 41. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
    Clergeot A; Steru D; Rosset MA; Carbon C
    J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infections.
    Naber KG; Dette GA; Kees F; Knothe H; Grobecker H
    J Antimicrob Chemother; 1986 Apr; 17(4):517-27. PubMed ID: 3710959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
    Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
    Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New Delhi metallo-β-lactamase (NDM-1): an update.
    Shakil S; Azhar EI; Tabrez S; Kamal MA; Jabir NR; Abuzenadah AM; Damanhouri GA; Alam Q
    J Chemother; 2011 Oct; 23(5):263-5. PubMed ID: 22005056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microbiology and pharmacology of aztreonam.
    Duma RJ
    Urology; 1988 Jun; 31(6 Suppl):9-13. PubMed ID: 3287750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-lactamase stability and in vitro activity of aztreonam, with a comparison to 9 other beta-lactam antibiotics and gentamicin.
    Friis H; Prag J; Togsverd E; Benson MW
    Chemotherapy; 1986; 32(4):329-35. PubMed ID: 3488177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
    Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
    Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fundamental and clinical studies on aztreonam in obstetrics and gynecology].
    Shimizu T; Haga H; Sakuraba M; Yamashita K; Ishikawa M; Torii Y; Mizoguchi H; Yamazaki T; Yorozu Y; Mure K
    Jpn J Antibiot; 1985 Dec; 38(12):3505-12. PubMed ID: 3834133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fundamental and clinical studies on aztreonam in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1985 Nov; 38(11):3273-84. PubMed ID: 4094059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical experience with aztreonam in Germany and Austria.
    Stille W; Gillissen J
    Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden.
    Norrby SR
    Rev Infect Dis; 1985; 7 Suppl 4():S836-9. PubMed ID: 2934788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapy.
    Winston DJ; Ho WG; Champlin RE; Gale RP; Busuttil RW
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():55-66. PubMed ID: 3086277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical evaluation of aztreonam for complicated urinary tract infection].
    Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Laboratory and clinical studies on aztreonam in the pediatric field].
    Hosoda T; Masuda M; Miyao M
    Jpn J Antibiot; 1985 Nov; 38(11):3343-8. PubMed ID: 4094067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
    McKellar PP
    Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Preclinical and clinical studies on aztreonam in obstetrics and gynecology].
    Seki H; Maki M
    Jpn J Antibiot; 1985 Dec; 38(12):3520-6. PubMed ID: 3834134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
    Simons WJ; Lee TJ
    Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.
    Rusconi F; Assael BM; Boccazzi A; Colombo R; Crossignani RM; Garlaschi L; Rancilio L
    Antimicrob Agents Chemother; 1986 Aug; 30(2):310-4. PubMed ID: 3094442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.